EUVIMEDObjevte EUVIMED
Crossref

hsa-miR-9 and drug control over the P38 network as driving disease outcome in GBM patients

Rotem Ben-Hamo, Sol Efroni

Systems Biomedicine · 2013

DOI: 10.4161/sysb.25815 ↗

At a glance

Journal article in Systems Biomedicine, 2013. Written by Rotem Ben-Hamo and 1 co-authors. 32 references.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

Ben-Hamo, R., & Efroni, S. (2013). hsa-miR-9 and drug control over the P38 network as driving disease outcome in GBM patients. Systems Biomedicine. https://doi.org/10.4161/sysb.25815

Vancouver

Ben-Hamo R, Efroni S. hsa-miR-9 and drug control over the P38 network as driving disease outcome in GBM patients. Systems Biomedicine. 2013. doi:10.4161/sysb.25815

BibTeX
@article{BenHamo2013,
  author = {Ben-Hamo, Rotem and Efroni, Sol},
  title = {hsa-miR-9 and drug control over the P38 network as driving disease outcome in GBM patients},
  journal = {Systems Biomedicine},
  year = {2013},
  doi = {10.4161/sysb.25815}
}
Start for free →